Clinical trial
Effects of Letrozole on Precocious Puberty Due to McCune Albright Syndrome
NCT00006174 · National Institute of Dental and Craniofacial Research (NIDCR), NIH · Completed
Key facts
| NCT number | NCT00006174 |
|---|---|
| Title | Effects of Letrozole on Precocious Puberty Due to McCune Albright Syndrome |
| Official title | Effects of the Aromatase Inhibitor Letrozole on Pubertal Progression and Indices of Bone Turnover in Girls With Precocious Puberty and McCune-Albright Syndrome (MAS) |
| Lead sponsor | National Institute of Dental and Craniofacial Research (NIDCR), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | McCune Albright Syndrome, Polyostotic Fibrous Dysplasia, Precocious Puberty |
| Intervention type | Drug |
| Interventions | Letrozole |
| Enrollment | 25 |
| Start date | Aug 3, 2000 |
| Completion | May 18, 2009 |
| First posted | Aug 14, 2000 |
| Last update posted | Jul 2, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: